Updates to the Prescribing Medicines in Pregnancy database, December 2022

The Prescribing Medicines in Pregnancy database has now been updated to include the following new entries: 

• asciminib hydrochloride - pregnancy category D
• anifrolumab - pregnancy category C
• bilastine - pregnancy category B3
• bimekizumab - pregnancy category C
• clobetasol - pregnancy category B3
• difelikefalin - pregnancy category B1
• diroximel fumarate - pregnancy category B3
• dostarlimab - pregnancy category D
• estetrol (as monohydrate) - pregnancy category B3
• faricimab - pregnancy category D
• influenza vaccine (seasonal; recombinant ) - pregnancy category B1
• maribavir - pregnancy category D
• mobocertinib succinate - pregnancy category D
• osilodrostat - pregnancy category D
• patisiran - pregnancy category D
• pegcetacoplan - pregnancy category B3
• pemigatinib - pregnancy category D
• ponesimod - pregnancy category D
• pneumococcal vaccine, polysaccharides conjugate - pregnancy category B1
• rabies vaccine (inactivated) - pregnancy category B2
• selumetinib - pregnancy category D
• selinexor - pregnancy category D
• somapacitan - pregnancy category B1
• somatrogon - pregnancy category B1
• sotorasib - pregnancy category B3
• tepotinib - pregnancy category D
• tixagevimab; cilgavimab - pregnancy category B2
• trastuzumab deruxtecan - pregnancy category D
• treosulfan - pregnancy category D
• vosoritide - pregnancy category B2

The following entries have been amended:

• COVID-19 Vaccine -  ChAdOx1-S - pregnancy category from B2 to B1
• COVID-19 Vaccine -  elasomeran - change of name: COVID-19 Vaccine (mRNA)
• COVID-19 Vaccine - tozinameran - change of name: COVID-19 Vaccine (mRNA)
• pneumococcal vaccine, 23-valent polysaccharide or 10- or 13-valent conjugate - change of name: pneumococcal vaccine, capsular polysaccharides
• COVID-19 Vaccine - SARS-CoV-2 rS (NVX-CoV2373) - change of name: COVID-19 Vaccine (recombinant protein)